Cannabis’ chemical diversity and its potential as a multi-target treatment for Alzheimer’s disease (AD) are at the center of a new review published in IBRO Neuroscience Reports.
The review categorizes the compounds found in cannabis into cannabinoids and non-cannabinoids, exploring their roles in combating AD-related pathological features. With AD’s complexity often rendering single-target therapies insufficient, researchers propose that a multi-target approach utilizing cannabis-derived compounds may offer more effective alternatives.
By synthesizing existing research, the study identifies knowledge gaps and facilitates comparative analysis to advance future studies. It highlights cannabis’s potential to address multiple facets of AD pathology, suggesting that the plant’s therapeutic compounds could provide valuable contributions to neurodegenerative disease research.
The authors emphasize the need for further investigation to better understand how cannabis-based treatments might be integrated into existing therapeutic strategies, offering a new perspective on tackling one of the most challenging neurological conditions.
Below is the study’s abstract:
Cannabis sativa is recognized for its chemical diversity and therapeutic potential, particularly in addressing neurodegenerative diseases such as Alzheimer’s disease (AD). Given the complexity of AD, where single-target therapies often prove inadequate, a multi-target approach utilizing cannabis-derived compounds may offer promising alternatives. This review first highlights the chemical diversity of cannabis by categorizing its compounds into cannabinoids and non-cannabinoids. It then examines studies investigating the effects of these compounds on AD-related pathological features. By synthesizing existing knowledge, identifying research gaps, and facilitating comparative analysis, this review aims to advance future research and understanding. It underscores cannabis’s potential as a multi-target therapeutic strategy for AD, contributing valuable insights to ongoing scientific discussions.
More articles from The Marijuana Herald can be found below.
